Where Global Innovation
and Capital Meet
Sectors ConsumerUniversityEnergyFinancialHealthcareIndustrialITMediaServicesTelecomsTransportThe Art of CVCStartups

Page 389

DraftKings and FanDuel mull billion-dollar merger

The daily fantasy sports businesses have raised a total of almost $750m from investors including Alphabet, Fox Sports, Time Warner, Comcast and NBC.

Jun 14, 2016

Move Loot delivers acquisition news

The second-hand furniture marketplace, backed by Alphabet and IDG, is in talks to be acquired by an as-yet unnamed "symbiotic company".

Jun 14, 2016

Imperial exits Alkion Biopharma

Imperial Innovations exits its investment in Imperial College London spinout Alkion Biopharma, selling its shares to chemical company Evonik Industries.

Jun 14, 2016

OneLogin moors itself in Portadi

OneLogin has bought cloud app management software developer Portadi for an undisclosed amount, a year after it graduated from Microsoft Ventures Accelerator.

Jun 13, 2016

China Online Education writes final IPO script

The Duowan Entertainment-backed English language learning platform has raised $45.6m in a US initial public offering and will secure another $20m through a private placement.

Jun 13, 2016

Big deal: Cambridge wins big returns

Cambridge Enterprise comes out on top for money returned on investments with impressive numbers across the board.

Jun 13, 2016

Smaato advertises $148m acquisition

Spearhead Integrated Marketing Communication has agreed to buy Smaato for $148m two years after the mobile advertising company raised series E funding from Singapore Press.

Jun 10, 2016

Line marches towards $1bn IPO

Naver-owned messaging platform Line is set to sell 13 million shares in Japan and 22 million shares in the US priced at $26.30 each for a dual listing.

Jun 10, 2016

Ergomed acquires Haemostatix

Drug developer Ergomed acquires Leicester spinout Haemostatix, which is developing a blood clotting peptide sequence, for $11.5m upfront and a potential future payment of $29m.

Jun 9, 2016
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here